ARGENX SE (1AE.DE) Fundamental Analysis & Valuation

FRA:1AE • NL0010832176

Current stock price

607 EUR
+5.2 (+0.86%)
Last:

This 1AE.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. 1AE.DE Profitability Analysis

1.1 Basic Checks

  • In the past year 1AE was profitable.
  • In multiple years 1AE reported negative net income over the last 5 years.
  • 1AE had a negative operating cash flow in each of the past 5 years.
1AE.DE Yearly Net Income VS EBIT VS OCF VS FCF1AE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 18.01%, 1AE belongs to the top of the industry, outperforming 93.67% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 21.20%, 1AE belongs to the top of the industry, outperforming 92.41% of the companies in the same industry.
  • 1AE's Return On Invested Capital of 12.24% is amongst the best of the industry. 1AE outperforms 91.14% of its industry peers.
Industry RankSector Rank
ROA 18.01%
ROE 21.2%
ROIC 12.24%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1AE.DE Yearly ROA, ROE, ROIC1AE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • 1AE has a Profit Margin of 31.12%. This is amongst the best in the industry. 1AE outperforms 89.87% of its industry peers.
  • With an excellent Operating Margin value of 25.68%, 1AE belongs to the best of the industry, outperforming 83.54% of the companies in the same industry.
  • 1AE has a better Gross Margin (89.15%) than 82.28% of its industry peers.
  • 1AE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.68%
PM (TTM) 31.12%
GM 89.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.34%
GM growth 5YN/A
1AE.DE Yearly Profit, Operating, Gross Margins1AE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. 1AE.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1AE is still creating some value.
  • 1AE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1AE.DE Yearly Shares Outstanding1AE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
1AE.DE Yearly Total Debt VS Total Assets1AE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 25.73 indicates that 1AE is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 25.73, 1AE belongs to the best of the industry, outperforming 97.47% of the companies in the same industry.
  • 1AE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • 1AE's Debt to Equity ratio of 0.01 is amongst the best of the industry. 1AE outperforms 89.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 25.73
ROIC/WACC1.65
WACC7.43%
1AE.DE Yearly LT Debt VS Equity VS FCF1AE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

  • 1AE has a Current Ratio of 5.60. This indicates that 1AE is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 5.60, 1AE belongs to the top of the industry, outperforming 83.54% of the companies in the same industry.
  • 1AE has a Quick Ratio of 5.27. This indicates that 1AE is financially healthy and has no problem in meeting its short term obligations.
  • 1AE has a better Quick ratio (5.27) than 84.81% of its industry peers.
Industry RankSector Rank
Current Ratio 5.6
Quick Ratio 5.27
1AE.DE Yearly Current Assets VS Current Liabilites1AE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. 1AE.DE Growth Analysis

3.1 Past

  • 1AE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1028.32%, which is quite impressive.
  • The Revenue has grown by 89.56% in the past year. This is a very strong growth!
  • The Revenue has been growing by 151.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1028.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%762.37%
Revenue 1Y (TTM)89.56%
Revenue growth 3Y116.21%
Revenue growth 5Y151.52%
Sales Q2Q%79.03%

3.2 Future

  • Based on estimates for the next years, 1AE will show a very strong growth in Earnings Per Share. The EPS will grow by 30.38% on average per year.
  • 1AE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.88% yearly.
EPS Next Y42.94%
EPS Next 2Y35.43%
EPS Next 3Y35.35%
EPS Next 5Y30.38%
Revenue Next Year38.91%
Revenue Next 2Y30.38%
Revenue Next 3Y25.88%
Revenue Next 5Y20.88%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1AE.DE Yearly Revenue VS Estimates1AE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
1AE.DE Yearly EPS VS Estimates1AE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 20 40 60 80

More info and screens

Find the best growth stocksShow best growing peers

4

4. 1AE.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 35.87, the valuation of 1AE can be described as expensive.
  • 1AE's Price/Earnings ratio is a bit cheaper when compared to the industry. 1AE is cheaper than 78.48% of the companies in the same industry.
  • 1AE is valuated rather expensively when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 25.10, the valuation of 1AE can be described as expensive.
  • Based on the Price/Forward Earnings ratio, 1AE is valued cheaper than 81.01% of the companies in the same industry.
  • 1AE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 35.87
Fwd PE 25.1
1AE.DE Price Earnings VS Forward Price Earnings1AE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1AE.DE Per share data1AE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • 1AE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1AE has a very decent profitability rating, which may justify a higher PE ratio.
  • 1AE's earnings are expected to grow with 35.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.84
PEG (5Y)N/A
EPS Next 2Y35.43%
EPS Next 3Y35.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1AE.DE Dividend Analysis

5.1 Amount

  • No dividends for 1AE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1AE.DE Fundamentals: All Metrics, Ratios and Statistics

ARGENX SE

FRA:1AE (3/27/2026, 7:00:00 PM)

607

+5.2 (+0.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners44.15%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap37.56B
Revenue(TTM)4.15B
Net Income(TTM)1.29B
Analysts84
Price Target879.44 (44.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.65%
Min EPS beat(2)18.63%
Max EPS beat(2)28.67%
EPS beat(4)4
Avg EPS beat(4)19.4%
Min EPS beat(4)7.11%
Max EPS beat(4)28.67%
EPS beat(8)6
Avg EPS beat(8)2001.9%
EPS beat(12)9
Avg EPS beat(12)1341.88%
EPS beat(16)12
Avg EPS beat(16)1013.46%
Revenue beat(2)2
Avg Revenue beat(2)3.6%
Min Revenue beat(2)0.3%
Max Revenue beat(2)6.9%
Revenue beat(4)3
Avg Revenue beat(4)3.64%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)8.17%
Revenue beat(8)6
Avg Revenue beat(8)3.1%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.23%
PT rev (3m)4%
EPS NQ rev (1m)-11.94%
EPS NQ rev (3m)-12.26%
EPS NY rev (1m)-6.94%
EPS NY rev (3m)-4.19%
Revenue NQ rev (1m)1.66%
Revenue NQ rev (3m)1.58%
Revenue NY rev (1m)1.54%
Revenue NY rev (3m)2.06%
Valuation
Industry RankSector Rank
PE 35.87
Fwd PE 25.1
P/S 10.44
P/FCF N/A
P/OCF N/A
P/B 7.11
P/tB 7.38
EV/EBITDA N/A
EPS(TTM)16.92
EY2.79%
EPS(NY)24.18
Fwd EY3.98%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS58.14
BVpS85.37
TBVpS82.3
PEG (NY)0.84
PEG (5Y)N/A
Graham Number180.27
Profitability
Industry RankSector Rank
ROA 18.01%
ROE 21.2%
ROCE 17.38%
ROIC 12.24%
ROICexc 34.03%
ROICexgc 37.78%
OM 25.68%
PM (TTM) 31.12%
GM 89.15%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.34%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.6
Quick Ratio 5.27
Altman-Z 25.73
F-ScoreN/A
WACC7.43%
ROIC/WACC1.65
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1028.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%762.37%
EPS Next Y42.94%
EPS Next 2Y35.43%
EPS Next 3Y35.35%
EPS Next 5Y30.38%
Revenue 1Y (TTM)89.56%
Revenue growth 3Y116.21%
Revenue growth 5Y151.52%
Sales Q2Q%79.03%
Revenue Next Year38.91%
Revenue Next 2Y30.38%
Revenue Next 3Y25.88%
Revenue Next 5Y20.88%
EBIT growth 1Y7710.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year77.31%
EBIT Next 3Y46.52%
EBIT Next 5Y34.92%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ARGENX SE / 1AE.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ARGENX SE (1AE.DE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1AE.DE.


Can you provide the valuation status for ARGENX SE?

ChartMill assigns a valuation rating of 4 / 10 to ARGENX SE (1AE.DE). This can be considered as Fairly Valued.


How profitable is ARGENX SE (1AE.DE) stock?

ARGENX SE (1AE.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for 1AE stock?

The financial health rating of ARGENX SE (1AE.DE) is 7 / 10.


Can you provide the expected EPS growth for 1AE stock?

The Earnings per Share (EPS) of ARGENX SE (1AE.DE) is expected to grow by 42.94% in the next year.